Aristo Pharma Nordic ApS: Financial statements 2015
CVR: 32328768
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
Aristo Pharma Nordic ApS (CVR 32328768) has filed annual accounts for 2015. In 2015, the company reported a gross profit of EUR 145,002 and a net result of EUR -1,602,082 compared with EUR -1,668,647 the year before. Equity in the 2015 report amounted to EUR -2,661,340. The company had 11 employees in the financial year.
- Gross Profit
- EUR 145,002
- Profit/Loss
- EUR -1,602,082
- Equity
- EUR -2,661,340
- Total Assets
- EUR 3,222,166
- Employees
- 11
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 145K EUR | -1.6M EUR | -2.7M EUR | 11 |
| 2014 | - | -734K EUR | -1.7M EUR | -1.1M EUR | 12 |
| 2012 | - | -297K | -428K | -484K | - |
Official annual report
How creditworthy is Aristo Pharma Nordic ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of December 31, 2015, Lena Storm Christensen is registered as director of Aristo Pharma Nordic ApS.
As of December 31, 2015, Svend Aage Johansen has stepped down as adm. dir. of Aristo Pharma Nordic ApS.
Aristo Pharma Nordic ApS has published its annual report for 2014. Gross profit came to DKK -733,672, and the net result was DKK -1,668,647.
As of April 28, 2015, János Váczi has joined the board of directors of Aristo Pharma Nordic ApS.
As of April 10, 2015, János Váczi has left the board of directors of Aristo Pharma Nordic ApS.
As of March 17, 2015, János Váczi has joined the board of directors of Aristo Pharma Nordic ApS.
As of March 17, 2015, Chirag K Patel has joined the board of directors of Aristo Pharma Nordic ApS.
As of March 17, 2015, Chintu Patel has joined the board of directors of Aristo Pharma Nordic ApS.
As of March 17, 2015, Joseph Todisco has left the board of directors of Aristo Pharma Nordic ApS.
As of March 17, 2015, Peter Prock has left the board of directors of Aristo Pharma Nordic ApS.
About Aristo Pharma Nordic ApS
Aristo Pharma Nordic ApS is a Danish company of the type Anpartsselskab based in Skovlunde, founded in 2011. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named AMNEAL NORDIC ApS and COPHARMA ApS. The management consists of John Hudson Kriwet. The board consists of John Hudson Kriwet (chair), Jannes Paul Beeskow and Robert Maciej Szymanski. The company is owned by Aristo Pharma GmbH. The company has 1 employee (2026). In 2025, the company reported revenue of EUR 453,392 and a net result of EUR 21,589 compared with EUR 25,190 the year before. Equity in the 2025 report amounted to EUR 184,874.